Literature DB >> 12270694

Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment.

G B Bishop1, W E Cullinan, E Curran, H B Gutstein.   

Abstract

While different classes of abused drugs interact with distinct signaling substrates, it appears that all utilize receptors in the mesolimbic dopamine system to mediate their reinforcing effects. The regulator of G-protein signaling (RGS) proteins modulate G-protein coupled receptor (GPCR) signaling by increasing the rate of GTP hydrolysis of G proteins. This study was undertaken to determine whether morphine, cocaine, or amphetamine would modulate RGS4 mRNA levels in relevant brain regions. Acute administration of morphine and cocaine decreased levels of RGS4 mRNA in the reticulotegmental pontine nucleus (RtTg) and locus coeruleus (LC). Increases in RGS 4 mRNA levels were observed in the nucleus accumbens (NAc) and dorsal central gray (CGD). Acute drug challenge after chronic drug administration increased RGS4 mRNA in the CGD and decreased RGS4 levels in the red nucleus and RtTg. Interestingly, the LC exhibited biphasic modulation, with decreased RGS4 mRNA levels after acute administration and increased levels after chronic administration. These findings indicate that RGS4 mRNA levels are modulated in a similar manner by different drugs of abuse and imply that a common substrate could mediate some effects of abused drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270694     DOI: 10.1006/nbdi.2002.0518

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  19 in total

Review 1.  Drosophila, a genetic model system to study cocaine-related behaviors: a review with focus on LIM-only proteins.

Authors:  Ulrike Heberlein; Linus T-Y Tsai; David Kapfhamer; Amy W Lasek
Journal:  Neuropharmacology       Date:  2008-07-24       Impact factor: 5.250

2.  Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics.

Authors:  Ada M-C Ho; Rachel K MacKay; Peter R Dodd; Joanne M Lewohl
Journal:  Brain Res       Date:  2010-04-27       Impact factor: 3.252

3.  Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.

Authors:  Qin Wang; John R Traynor
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 4.  Regulators of G Protein Signaling in Analgesia and Addiction.

Authors:  Farhana Sakloth; Claire Polizu; Feodora Bertherat; Venetia Zachariou
Journal:  Mol Pharmacol       Date:  2020-05-30       Impact factor: 4.436

5.  Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex.

Authors:  P J Ebert; D B Campbell; P Levitt
Journal:  Neuroscience       Date:  2006-09-25       Impact factor: 3.590

Review 6.  μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  John Traynor
Journal:  Drug Alcohol Depend       Date:  2011-11-29       Impact factor: 4.492

Review 7.  Addictive drugs modulate GIRK-channel signaling by regulating RGS proteins.

Authors:  Marta Lomazzi; Paul A Slesinger; Christian Lüscher
Journal:  Trends Pharmacol Sci       Date:  2008-09-12       Impact factor: 14.819

8.  Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.

Authors:  M Scott Bowers; Krista McFarland; Russell W Lake; Yuri K Peterson; Christopher C Lapish; Mary Lee Gregory; Stephen M Lanier; Peter W Kalivas
Journal:  Neuron       Date:  2004-04-22       Impact factor: 17.173

Review 9.  Regulation of psychostimulant-induced signaling and gene expression in the striatum.

Authors:  Jacqueline F McGinty; Xiangdang D Shi; Marek Schwendt; Alicia Saylor; Shigenobu Toda
Journal:  J Neurochem       Date:  2008-01-21       Impact factor: 5.372

10.  Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.

Authors:  Ming-Hi Han; Willam Renthal; Robert H Ring; Zia Rahman; Kassi Psifogeorgou; David Howland; Shari Birnbaum; Kathleen Young; Rachael Neve; Eric J Nestler; Venetia Zachariou
Journal:  Biol Psychiatry       Date:  2009-11-14       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.